Cas:6759-80-4 2,5,7-trimethylquinolin-8-ol manufacturer & supplier

We serve Chemical Name:2,5,7-trimethylquinolin-8-ol CAS:6759-80-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2,5,7-trimethylquinolin-8-ol

Chemical Name:2,5,7-trimethylquinolin-8-ol
CAS.NO:6759-80-4
Synonyms:8-Hydroxy-2,5,7-trimethylchinolin;2,3,7-Trimethyl-8-hydroxychinolin;2,5,7-trimethyl-quinolin-8-ol;2,5,7-Trimethyl-8-hydroxychinolin;8-hydroxy-2,5,7-trimethylquinoline;2,4-DICHLORO-3-NITROBENZOTRIFLUORIDE;2,5,7-Trimethyl-8-quinolinol
Molecular Formula:C12H13NO
Molecular Weight:187.23800
HS Code:2933499090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:330.8ºC at 760 mmHg
Density:1.141g/cm3
Index of Refraction:1.632
PSA:33.12000
Exact Mass:187.10000
LogP:2.86560

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 8-Hydroxy-2,5,7-trimethylchinolin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,5,7-Trimethyl-8-quinolinol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,5,7-Trimethyl-8-hydroxychinolin Use and application,2,5,7-Trimethyl-8-quinolinol technical grade,usp/ep/jp grade.


Related News: Today’s decisions represent progress in our continued efforts to make a difference in this pandemic on a global scale, Kathy Wengel, J&J’s chief global supply chain officer, said in the statement. 2,5,7-trimethylquinolin-8-ol manufacturer Ultimately there’s likely a broad mix of social, cultural and economic drivers at play, suggested Lona Sandon, program director of the Department of Clinical Nutrition in the School of Health Professions at the UT Southwestern Medical Center in Dallas. She was not part of the research. 2,5,7-trimethylquinolin-8-ol supplier There’s still hope for this approach to treating Alzheimer’s disease despite the somewhat mixed results from this trial, said Rebecca Edelmayer, senior director of scientific engagement at the Alzheimer’s Association. 2,5,7-trimethylquinolin-8-ol vendor To persuade doctors to stop treatment for a traditionally continuous therapy, AbbVie and J&J likely also need to show that doing so won’t hurt patients’ chance at successful retreatment if their cancer does rebound early. 2,5,7-trimethylquinolin-8-ol factory Today’s decisions represent progress in our continued efforts to make a difference in this pandemic on a global scale, Kathy Wengel, J&J’s chief global supply chain officer, said in the statement.